This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Biotech ETFs Bounce Back in 2025: Here's Why
by Sanghamitra Saha
Biotech ETFs rally. IBB, ARKG, SBIO, BBC, CANC and BBP soar as Fed rate cut optimism, FDA approvals, deals and cheaper valuations drive the space in 2025.
Best-Performing ETFs of Last Week
by Sanghamitra Saha
Wall Street was upbeat last week, despite the release of hot January inflation data.
Best-Performing ETF Areas of Last Week
by Sanghamitra Saha
Wall Street was upbeat last week with the Dow Jones and the S&P 500 hitting all-time highs last week.
The Zacks Analyst Blog Highlights Invesco DWA Technology Momentum ETF, Strive U.S. Semiconductor ETF, Invesco PHLX Semiconductor ETF, VanEck Vectors Semiconductor ETF and ARK Genomic Revolution ETF
by Zacks Equity Research
Invesco DWA Technology Momentum ETF, Strive U.S. Semiconductor ETF, Invesco PHLX Semiconductor ETF, VanEck Vectors Semiconductor ETF and ARK Genomic Revolution ETF are included in this Analyst Blog.
5 Technology ETFs at the Forefront of the August Rebound
by Sweta Killa
Wall Street roared back after a sell-off early in the month as fears of recession eased. The technology sector, which bore the biggest brunt, rebounded strongly and once again led the market over the past week.
Best ETF Areas of July
by Sanghamitra Saha
July witnessed the "Great Rotation" in the U.S. stock market on an apparent "AI Fatigue."
The Zacks Analyst Blog Highlights QABA, ITB, XTL, ARKG and SLVP
by Zacks Equity Research
QABA, ITB, XTL, ARKG and SLVP are part of the Zacks top Analyst Blog.
5 Sector ETFs That Outperformed With Double-Digit Gains in July
by Sweta Killa
July witnessed the "Great Rotation" in the U.S. stock market as investors shunned the hot technology stocks in favor of smaller companies and other sectors, which are the bigger beneficiaries of the Fed rate cuts.
Best ETFs of Last Week
by Sanghamitra Saha
Wall Street offered a mixed performance last week.
Time to Tap Healthcare ETFs on Nvidia's AI Ambition?
by Sanghamitra Saha
At Nvidia's last week's GTC AI conference, the company announced partnerships in the healthcare sector, representing a strategic move toward expanding its revenue streams beyond tech sectors.